Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Advanced Laboratory Medicine, |
RCV000852472 | SCV000995166 | likely pathogenic | Arrhythmogenic right ventricular cardiomyopathy | 2017-02-02 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001858508 | SCV002151987 | pathogenic | Arrhythmogenic right ventricular dysplasia 10 | 2024-01-22 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Val295Serfs*6) in the DSG2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DSG2 are known to be pathogenic (PMID: 17105751, 31386562). This variant is present in population databases (no rsID available, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with arrhythmogenic right ventricular cardiomyopathy (PMID: 20400443, 30790397). This variant is also known as c.882_883insA. ClinVar contains an entry for this variant (Variation ID: 691669). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV002501181 | SCV002809385 | pathogenic | Arrhythmogenic right ventricular dysplasia 10; Dilated cardiomyopathy 1BB | 2022-05-03 | criteria provided, single submitter | clinical testing | |
Laboratorio de Genetica e Diagnostico Molecular, |
RCV001858508 | SCV004183382 | likely pathogenic | Arrhythmogenic right ventricular dysplasia 10 | 2020-12-16 | criteria provided, single submitter | clinical testing | ACMG classification criteria: PVS1, PM2 |